Potential risk factors of blood coagulation and fibrinolysis in the development of stroke

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

44 young stroke patiens (under age 50) were included in the study, who possessed no known underlying disorder (arteriosclerosis, atrial thrombi etc.). Our goal was to evaluate potential causes that might have precipitated the disorder. We tested haemostasis abnormalities which can cause thrombosis: antithrombin III activity by chromogenic assay, protein C, and protein S activities both by clotting method and activated protein C resistance by APTT based clotting assay. Levels of fibrinolytic factors were also measured: PAI-1 level by ELISA method and α2 antiplasmin activity. Because lipoprotein (a) has extensive structural homology with plasminogen and competes with plasminogen receptor, thereby reducing plasmin generation and causing thrombosis, we measured lipoprotein (a) level by ELISA method. Our results showed that there were 3 patiens with decreased AT- III activity, 4 patients with protein C, 5 with protein S deficiency and 4 had activated protein C resistance. Increase in lipoprotein (a) level was found in 11 patients out of 32 examined and PAI-1 level was higher than reference limit in 17 Patients out of 44 examined. 10 patients had normal values for all parameters tested and 11 patients had at least 3 identifiable risk factors of thrombosis. Based on our findings we conclude that the impairment of fibrinolysis seems to at least as prevalent in young patients with ischémie stroke, as deficiencies of inhibitors or APC resistance.

Original languageEnglish
Pages (from-to)136
Number of pages1
JournalFibrinolysis
Volume10
Issue numberSUPPL. 3
Publication statusPublished - 1996

Fingerprint

Blood Coagulation
Fibrinolysis
Stroke
Activated Protein C Resistance
Lipoprotein(a)
Thrombosis
Plasminogen
Plasminogen Activator Inhibitor 1
Protein C
Enzyme-Linked Immunosorbent Assay
Protein S Deficiency
Antifibrinolytic Agents
Antithrombin III
Arteriosclerosis
Fibrinolysin
Protein S
Hemostasis
Reference Values

ASJC Scopus subject areas

  • Hematology

Cite this

Potential risk factors of blood coagulation and fibrinolysis in the development of stroke. / Ajzner, E.; Kappelmayer, J.; Misz, M.

In: Fibrinolysis, Vol. 10, No. SUPPL. 3, 1996, p. 136.

Research output: Contribution to journalArticle

@article{3a0c9f8d0f184fa3893a69ba00b59c48,
title = "Potential risk factors of blood coagulation and fibrinolysis in the development of stroke",
abstract = "44 young stroke patiens (under age 50) were included in the study, who possessed no known underlying disorder (arteriosclerosis, atrial thrombi etc.). Our goal was to evaluate potential causes that might have precipitated the disorder. We tested haemostasis abnormalities which can cause thrombosis: antithrombin III activity by chromogenic assay, protein C, and protein S activities both by clotting method and activated protein C resistance by APTT based clotting assay. Levels of fibrinolytic factors were also measured: PAI-1 level by ELISA method and α2 antiplasmin activity. Because lipoprotein (a) has extensive structural homology with plasminogen and competes with plasminogen receptor, thereby reducing plasmin generation and causing thrombosis, we measured lipoprotein (a) level by ELISA method. Our results showed that there were 3 patiens with decreased AT- III activity, 4 patients with protein C, 5 with protein S deficiency and 4 had activated protein C resistance. Increase in lipoprotein (a) level was found in 11 patients out of 32 examined and PAI-1 level was higher than reference limit in 17 Patients out of 44 examined. 10 patients had normal values for all parameters tested and 11 patients had at least 3 identifiable risk factors of thrombosis. Based on our findings we conclude that the impairment of fibrinolysis seems to at least as prevalent in young patients with isch{\'e}mie stroke, as deficiencies of inhibitors or APC resistance.",
author = "E. Ajzner and J. Kappelmayer and M. Misz",
year = "1996",
language = "English",
volume = "10",
pages = "136",
journal = "Fibrinolysis and Proteolysis",
issn = "0268-9499",
publisher = "Churchill Livingstone",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Potential risk factors of blood coagulation and fibrinolysis in the development of stroke

AU - Ajzner, E.

AU - Kappelmayer, J.

AU - Misz, M.

PY - 1996

Y1 - 1996

N2 - 44 young stroke patiens (under age 50) were included in the study, who possessed no known underlying disorder (arteriosclerosis, atrial thrombi etc.). Our goal was to evaluate potential causes that might have precipitated the disorder. We tested haemostasis abnormalities which can cause thrombosis: antithrombin III activity by chromogenic assay, protein C, and protein S activities both by clotting method and activated protein C resistance by APTT based clotting assay. Levels of fibrinolytic factors were also measured: PAI-1 level by ELISA method and α2 antiplasmin activity. Because lipoprotein (a) has extensive structural homology with plasminogen and competes with plasminogen receptor, thereby reducing plasmin generation and causing thrombosis, we measured lipoprotein (a) level by ELISA method. Our results showed that there were 3 patiens with decreased AT- III activity, 4 patients with protein C, 5 with protein S deficiency and 4 had activated protein C resistance. Increase in lipoprotein (a) level was found in 11 patients out of 32 examined and PAI-1 level was higher than reference limit in 17 Patients out of 44 examined. 10 patients had normal values for all parameters tested and 11 patients had at least 3 identifiable risk factors of thrombosis. Based on our findings we conclude that the impairment of fibrinolysis seems to at least as prevalent in young patients with ischémie stroke, as deficiencies of inhibitors or APC resistance.

AB - 44 young stroke patiens (under age 50) were included in the study, who possessed no known underlying disorder (arteriosclerosis, atrial thrombi etc.). Our goal was to evaluate potential causes that might have precipitated the disorder. We tested haemostasis abnormalities which can cause thrombosis: antithrombin III activity by chromogenic assay, protein C, and protein S activities both by clotting method and activated protein C resistance by APTT based clotting assay. Levels of fibrinolytic factors were also measured: PAI-1 level by ELISA method and α2 antiplasmin activity. Because lipoprotein (a) has extensive structural homology with plasminogen and competes with plasminogen receptor, thereby reducing plasmin generation and causing thrombosis, we measured lipoprotein (a) level by ELISA method. Our results showed that there were 3 patiens with decreased AT- III activity, 4 patients with protein C, 5 with protein S deficiency and 4 had activated protein C resistance. Increase in lipoprotein (a) level was found in 11 patients out of 32 examined and PAI-1 level was higher than reference limit in 17 Patients out of 44 examined. 10 patients had normal values for all parameters tested and 11 patients had at least 3 identifiable risk factors of thrombosis. Based on our findings we conclude that the impairment of fibrinolysis seems to at least as prevalent in young patients with ischémie stroke, as deficiencies of inhibitors or APC resistance.

UR - http://www.scopus.com/inward/record.url?scp=0242487452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242487452&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 136

JO - Fibrinolysis and Proteolysis

JF - Fibrinolysis and Proteolysis

SN - 0268-9499

IS - SUPPL. 3

ER -